Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2
X. Yang, R. J. Dickmander, A. Bayati, S. A. Taft-Benz, J. L. Smith, C. I. Wells, E. A. Madden, J. W. Brown, E. M. Lenarcic, B. L. Yount, E. Chang, A. D. Axtman, R. S. Baric, M. T. Heise, P. S. McPherson, , T. M. Willson
The paper shows that inhibiting the kinase CSNK2 blocks replication of several beta-coronaviruses, including SARS-CoV-2, by preventing viral entry.
bioRxiv · Jan 3, 2022 · PreprintCell Biology